6.04
+0.15(+2.55%)
Currency In USD
| Previous Close | 5.89 |
| Open | 5.81 |
| Day High | 6.14 |
| Day Low | 5.73 |
| 52-Week High | 78.05 |
| 52-Week Low | 3.6 |
| Volume | 59,434 |
| Average Volume | 143,916 |
| Market Cap | 41.99M |
| PE | -0.4 |
| EPS | -15.27 |
| Moving Average 50 Days | 5.04 |
| Moving Average 200 Days | 15.88 |
| Change | 0.15 |
If you invested $1000 in Scilex Holding Company (SCLX) since IPO date, it would be worth $17.52 as of July 02, 2025 at a share price of $6.04. Whereas If you bought $1000 worth of Scilex Holding Company (SCLX) shares 3 years ago, it would be worth $16.85 as of July 02, 2025 at a share price of $6.04.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to a future date to be determined by the Board
GlobeNewswire Inc.
Jun 23, 2025 8:50 PM GMT
PALO ALTO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for
Scilex Holding Company Announces Publication on GLOPERBA® Dosing Adjustments in Peer-Review Journal
GlobeNewswire Inc.
Jun 05, 2025 4:05 PM GMT
PALO ALTO, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for
Scilex Holding Company Presented Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional Pain Physicians (ASIPP), May 15-17, 2025 in Orlando, FL
GlobeNewswire Inc.
May 16, 2025 1:00 PM GMT
PALO ALTO, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for